Seligman Center for Advanced Therapeutics, NYU Hospital for Joint Diseases — New York, New York

Seligman Center for Advanced Therapeutics, NYU Hospital for Joint Diseases is a clinical research site located in New York, New York, United States 10003.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Seligman Center for Advanced Therapeutics, NYU Hospital for Joint Diseases has participated in 1 clinical trials.

Therapeutic areas: Lupus Erythematosus, Systemic, Lupus Nephritis.

Sponsors: La Jolla Pharmaceutical Company.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Seligman Center for Advanced Therapeutics, NYU Hospital for Joint Diseases?

Seligman Center for Advanced Therapeutics, NYU Hospital for Joint Diseases has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Seligman Center for Advanced Therapeutics, NYU Hospital for Joint Diseases conducted?

Seligman Center for Advanced Therapeutics, NYU Hospital for Joint Diseases has 1 clinical trials on record. Their work covers Lupus Erythematosus, Systemic, Lupus Nephritis.

Is Seligman Center for Advanced Therapeutics, NYU Hospital for Joint Diseases accredited by Crixeo Health?

Seligman Center for Advanced Therapeutics, NYU Hospital for Joint Diseases has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Seligman Center for Advanced Therapeutics, NYU Hospital for Joint Diseases?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.